Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Swedish Orphan Biovitrum    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM

(SOBI)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Global Stocks Wobble as Earnings Season Gets Under Way

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2019 | 07:50am EDT

By Lauren Almeida

-- U.S. stock futures broadly flat

-- Asian, European indexes muted

-- U.S. Treasury yields fall

Global stocks wavered Wednesday ahead of another batch of earnings reports from major U.S. companies.

In Europe, the Stoxx Europe 600 switched between small losses and gains after a mixed session in Asia. Telecommunications equipment maker Ericsson suffered one of the biggest falls, with a drop of more than 6% on concerns about higher costs that led to a narrower-than-expected operating margin, according to Citigroup analysts.

Drugmaker Swedish Orphan Biovitrum had one of the strongest showings in the region, with its stock soaring as much as 13% after the company boosted its full-year forecast.

S&P 500 futures were broadly flat. The contracts don't necessarily predict moves after markets open.

Bank of America's shares slipped 0.3% in premarket trade Wednesday after it reported a profit in its most recent quarter. Netflix, eBay and Alcoa are due to report later in the day.

Amazon fell by 0.4% in U.S. premarket trading after the European Commission said it would launch an antitrust investigation into its dealings with third-party merchants. The move is part of a wider push from the European Union against American tech giants such as Facebook and Google-parent Alphabet.

The yield on 10-year Treasurys fell to 2.089% Wednesday from 2.124% Tuesday. Yields fall when bond prices rise.

The WSJ Dollar Index, which measures the currency against a basket of peers, was flat.

Federal Reserve Chairman Jerome Powell told an audience in Paris on Tuesday that the central bank is "carefully monitoring" downside risks to U.S. growth, strengthening expectations of an interest-rate cut.

Elsewhere, bitcoin fell by about 2.6%, trading below $10,000 for a second day as U.S. senators questioned Facebook over its proposed Libra cryptocurrency, highlighting the skepticism that digital-coin systems face from regulators.

Bitcoin, the world's most popular cryptocurrency, has lost almost a third of its value, according to prices from research site CoinDesk, after trading above $13,000 a week ago, which was near its high for the year.

The U.S. Commerce Department is set to release June housing starts data later Wednesday. Economists surveyed by The Wall Street Journal expect housing starts climbed 0.1% in June.

Global oil benchmark Brent crude rose by 0.9% to $64.93 a barrel. Gold was down by 0.5%.

Write to Lauren Almeida at lauren.almeida@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
ALCOA CORPORATION -2.27% 18.05 Delayed Quote.-32.09%
ALPHABET -0.01% 1191.52 Delayed Quote.14.03%
BITCOIN - EURO 0.66% 9184.6775 End-of-day quote.172.02%
BITCOIN - UNITED STATES DOLLAR 0.51% 10164.931 End-of-day quote.164.66%
CITIGROUP INC. 1.04% 63.91 Delayed Quote.22.76%
DJ INDUSTRIAL 0.19% 26252.24 Delayed Quote.12.54%
EBAY INC. -0.94% 40 Delayed Quote.42.50%
ERICSSON AB -2.58% 78.48 Delayed Quote.4.57%
EURO / US DOLLAR (EUR/USD) -0.14% 1.10692 Delayed Quote.-3.28%
FACEBOOK -0.82% 182.04 Delayed Quote.38.87%
LONDON BRENT OIL -0.17% 59.96 Delayed Quote.10.34%
NASDAQ 100 -0.33% 7707.427106 Delayed Quote.21.08%
NASDAQ COMP. -0.36% 7991.388419 Delayed Quote.19.79%
NETFLIX -0.30% 296.93 Delayed Quote.10.94%
OPEN BANK -3.79% 8.89 Delayed Quote.4.17%
S&P 500 -0.05% 2922.95 Delayed Quote.16.66%
STOXX EUROPE 600 -0.40% 374.29 Delayed Quote.9.97%
STOXX EUROPE 600 NR -0.38% 804.29 Delayed Quote.12.72%
SWEDISH ORPHAN BIOVITRUM -4.84% 170 Delayed Quote.-8.52%
US DOLLAR INDEX -0.13% 98.17 End-of-day quote.1.54%
WTI -0.23% 55.34 Delayed Quote.23.24%
This article is part of a news chaine.
Article 3 / 3
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SWEDISH ORPHAN BIOVITRUM
08/22ASTRAZENECA : to Buy US FDA Priority Review Voucher for $95 Million
DJ
08/22SWEDISH ORPHAN BIOVITRUM : Sobi has entered into agreement to sell Priority Revi..
AQ
07/18SWEDISH ORPHAN BIOVITRUM : Sobi completes acquisition of emapalumab and related ..
AQ
07/17WALL STREET STOCK EXCHANGE : Stocks Lower as Earnings Season Starts With Qualms ..
DJ
07/17WALL STREET STOCK EXCHANGE : U.S. Stocks Open Little Changed as Earnings Season ..
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17SWEDISH ORPHAN BIOVITRUM : Sobi publishes report for second quarter 2019
AQ
07/16SWEDISH ORPHAN BIOVITRUM : The Board of directors exercises authorisation for re..
PU
More news
Financials (SEK)
Sales 2019 13 585 M
EBIT 2019 4 104 M
Net income 2019 3 042 M
Debt 2019 7 562 M
Yield 2019 -
P/E ratio 2019 16,4x
P/E ratio 2020 14,0x
EV / Sales2019 4,24x
EV / Sales2020 3,63x
Capitalization 49 996 M
Chart SWEDISH ORPHAN BIOVITRUM
Duration : Period :
Swedish Orphan Biovitrum Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SWEDISH ORPHAN BIOVITRUM
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 229,17  SEK
Last Close Price 170,00  SEK
Spread / Highest target 85,3%
Spread / Average Target 34,8%
Spread / Lowest Target 7,06%
EPS Revisions
Managers
NameTitle
Guido Oelkers President & Chief Executive Officer
Sven Håkan Björklund Chairman
Anne Marie de Jonge Schuermans Head-Technical Operations
Henrik Stenqvist Chief Financial Officer
An van Es Johansson Vice President-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
SWEDISH ORPHAN BIOVITRUM-8.52%5 459
JOHNSON & JOHNSON1.20%347 129
ROCHE HOLDING LTD.12.16%238 668
MERCK AND COMPANY13.74%222 522
NOVARTIS17.97%206 833
PFIZER-20.71%192 868